Repligen (RGEN) Total Current Liabilities (2011 - 2026)
Repligen (RGEN) reported Total Current Liabilities of $126.2 million for Q1 2026, down 16.97% year-over-year from $152.0 million in Q1 2025, and down 7.08% quarter-over-quarter from $135.8 million in Q4 2025.
Repligen (RGEN) Total Current Liabilities (2011 - 2026) Analysis & Trends
Repligen (RGEN) has 16 years of Total Current Liabilities data on file, last reported at $126.2 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $126.2 million, down 16.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $126.2 million (down 16.97% YoY), and the FY2025 annual result was $135.8 million, up 7.13% from the prior year.
- Total Current Liabilities declined to $126.2 million in Q1 2026 per RGEN's latest filing, from $135.8 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $424.3 million in Q1 2022 and troughed at $108.4 million in Q3 2024.
- A 5-year average of $251.2 million and a median of $174.8 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities soared 35.43% in 2022, then sank 71.4% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $404.2 million in 2022, then tumbled by 59.19% to $164.9 million in 2023, then slipped by 23.13% to $126.8 million in 2024, then increased by 7.13% to $135.8 million in 2025, then slipped by 7.08% to $126.2 million in 2026.
- Business Quant data shows RGEN's Total Current Liabilities at $126.2 million in Q1 2026, $135.8 million in Q4 2025, and $131.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 126.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.21 Mn |
| Dec 31, 2025 | 135.83 Mn |
| Sep 30, 2025 | 131.14 Mn |
| Jun 30, 2025 | 123.01 Mn |
| Mar 31, 2025 | 152.00 Mn |
| Dec 31, 2024 | 126.79 Mn |
| Sep 30, 2024 | 108.37 Mn |
| Jun 30, 2024 | 174.81 Mn |
| Mar 31, 2024 | 181.55 Mn |
| Dec 31, 2023 | 164.94 Mn |
| Sep 30, 2023 | 378.94 Mn |
| Jun 30, 2023 | 388.35 Mn |
| Mar 31, 2023 | 416.56 Mn |
| Dec 31, 2022 | 404.20 Mn |
| Sep 30, 2022 | 410.70 Mn |
| Jun 30, 2022 | 423.52 Mn |
| Mar 31, 2022 | 424.33 Mn |
| Dec 31, 2021 | 375.26 Mn |
| Sep 30, 2021 | 349.44 Mn |
| Jun 30, 2021 | 332.34 Mn |